Biliary Stricture Clinical Trial
Official title:
Role of Biodegradable Polydioxanone Biliary Stents for the Percutaneous Treatment of Benign Biliary Strictures.
Verified date | February 2023 |
Source | Corporacion Parc Tauli |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
To assess safety and effectiveness in the long term of percutaneous insertion of Biodegradable (BD) Biliary Stents for the treatment of benign biliary strictures, in a single center experience.
Status | Completed |
Enrollment | 50 |
Est. completion date | December 20, 2022 |
Est. primary completion date | November 5, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - All patients over 18 years old attended in the interventional radiology department for the implantation of a biodegradable biliary stent (BBS: ELLA-CS, Hradec Kralove, Czech Republic), for each stenosis, by percutaneous technique. - Written informed consent given Exclusion Criteria: - Patients under 18 years old - Patients with post-liver transplant biliary strictures - Patients for whom no post-intervention follow-up data are available - Patients in whom malignancy is demonstrated as a cause of the stricture after stent placement. |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital Parc Tauli Sabadell | Sabadell |
Lead Sponsor | Collaborator |
---|---|
Corporacion Parc Tauli | Universitat Autonoma de Barcelona |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Stent Primary Patency | Time until new intervention due to re-stenosis or occlusion (detected by clinical signs and symptoms and confirmed by blood-test disturbances and/or imaging tests) | Time from stent implantation to new intervention due to restenosis or occlusion detected by clinical signs and symptoms and confirmed by blood-test disturbances and/or imaging tests), assessed up to 60 months | |
Primary | Adverse Events | Major and minor complications. The Clavien-Dindo classification will be used for grading the severity of complications. | From stent implantation to completion of follow-up, up to 5 years | |
Secondary | Technical Success | To correctly deploy a biodegradable stent using a percutaneous approach covering the stricture with a residual stenosis of less than 30% of the lumen, and correct flow of contrast through it into the intestinal lumen | Immediate (during procedure) | |
Secondary | Length of Hospital Stay | number of days that patients spend in hospital to have the stent inserted, including a 24-48h control cholangiogram | nights from admission to perform the stent implantation to discharge of the patient from the hospital, assessed up to 365 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03115411 -
Prospective Evaluation of Winged Biliary Stent Patency in Patients With Benign Biliary Obstruction
|
N/A | |
Completed |
NCT02041390 -
Effect of Short Message Service Intervention on Stent Removal/Exchange Adherence in Patients With Benign Pancreaticobiliary Diseases
|
N/A | |
Recruiting |
NCT01439698 -
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry
|
N/A | |
Terminated |
NCT01413386 -
Efficacy and Safety of the Paclitaxel Eluting Covered Biliary Stent to the Common Covered Metallic Biliary Stent
|
N/A | |
Completed |
NCT01543256 -
WallFlex Biliary Fully Covered (FC) Chronic Pancreatitis Study
|
N/A | |
Enrolling by invitation |
NCT04572711 -
Prospective Evaluation of Biliary Tissue Sampling With ERCP
|
||
Recruiting |
NCT03229655 -
Evaluation of Sequential Stent Addition vs. Incremental Dilation & Stent Exchange for Management of Anastomotic Biliary Strictures After Liver Transplantation
|
N/A | |
Completed |
NCT02916199 -
Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method
|
N/A | |
Recruiting |
NCT01522573 -
T-EUS for Gastrointestinal Disorders: A Multicenter Registry
|
N/A | |
Recruiting |
NCT01524146 -
Photodynamic Therapy (PDT) Cholangiocarcinoma Registry
|
N/A | |
Completed |
NCT02281019 -
SpyGlass AMEA Registry
|
||
Recruiting |
NCT04010734 -
Primary Cholangioscopy Versus ERCP in the Diagnosis of Biliary Strictures
|
N/A | |
Not yet recruiting |
NCT06369896 -
Digital Single-operator Cholangioscopy and Intraductal Ultrasound for Nonicteric Biliary Strictures
|
||
Recruiting |
NCT04391153 -
FISH in Diagnosis of Biliary Stricture
|
N/A | |
Active, not recruiting |
NCT03997994 -
DIGEST I Drug Coated Balloon for Biliary Stricture
|
N/A | |
Enrolling by invitation |
NCT03951324 -
Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study
|
||
Unknown status |
NCT01085747 -
Endoscopic Treatment of Biliary Stricture Caused by Chronic Pancreatitis
|
N/A | |
Completed |
NCT02105181 -
Fully Covered Self-expandable Metal Stents (FCMS) in Benign Biliary Strictures
|
N/A | |
Recruiting |
NCT05761483 -
Endoscopic Management of Non-anastomotic Biliary Strictures Following Liver Transplantation.
|
||
Completed |
NCT03673033 -
Biliary Complications in Live Donor Liver Transplantation
|